![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
RD Spealman and J Bergman
Harvard Medical School, New England Regional Primate Research Center, Southborough, Massachusetts.
The effects of cocaine alone and after pretreatment with selective mu and kappa opioids were determined in squirrel monkeys trained to discriminate i.m. injections of cocaine from vehicle in a two-lever discrimination procedure. Lever pressing was maintained under a fixed ratio schedule of food presentation. When administered alone, cocaine engendered dose-related increases in the proportion of cocaine- appropriate responding with an average ED50 of 0.19 mg/kg. Pretreatment with the mu agonists morphine (0.3 and 1.0 mg/kg), levorphanol (0.03 and 0.1 mg/kg) and methadone (0.1 and 0.3 mg/kg), as well as the mu partial agonist buprenorphine (3.0 and 5.6 micrograms/kg), potentiated the discriminative stimulus effects of cocaine such that the cocaine dose-effect functions were shifted to the left and the average ED50 for cocaine was reduced maximally by about one order of magnitude. None of the mu agonists consistently substituted for cocaine when administered alone, indicating that the observed interactions were not simply the result of additive discriminative stimulus effects. A similar potentiation by mu agonists was observed for the effects of cocaine on fixed ratio response rate. In contrast to the mu agonists, pretreatment with the kappa agonists N-methyl-N-[7-(1-pyrrolidinyl)-1- oxaspiro[4,5]dec-8-yll-4- benzofuranacetamide (CI 977; 3.0 and 5.6 micrograms/kg) and benzeneacetamide methane sulfonate (U 50,488; 0.3 and 1.0 mg/kg) attenuated the discriminative stimulus effects of cocaine in most monkeys, resulting in a modest (2- to 3-fold) increase in the average ED50 for cocaine.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  J. K. Rowlett, D. M. Platt, and R. D. Spealman Cocaine-Like Discriminative Stimulus Effects of Heroin: Modulation by Selective Monoamine Transport Inhibitors J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 342 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Bidlack, D. J. Cohen, J. P. McLaughlin, R. Lou, Y. Ye, and M. P. Wentland 8-Carboxamidocyclazocine: A Long-Acting, Novel Benzomorphan J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 374 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Walsh, B. Geter-Douglas, E. C. Strain, and G. E. Bigelow Enadoline and Butorphanol: Evaluation of kappa -Agonists on Cocaine Pharmacodynamics and Cocaine Self-Administration in Humans J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 147 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Platt, D. M. Grech, J. K. Rowlett, and R. D. Spealman Discriminative Stimulus Effects of Morphine in Squirrel Monkeys: Stimulants, Opioids, and Stimulant-Opioid Combinations J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1092 - 1100. [Abstract] [Full Text]
|
|
|
|
|
|
N. K. Mello and S. S. Negus Effects of Kappa Opioid Agonists on Cocaine- and Food-Maintained Responding by Rhesus Monkeys J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 812 - 824. [Abstract] [Full Text]
|
|
|
|
|
|
J. K. Rowlett, K. M. Wilcox, and W. L. Woolverton Self-Administration of Cocaine-Heroin Combinations by Rhesus Monkeys: Antagonism by Naltrexone J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 61 - 69. [Abstract] [Full Text]
|
|
|
|
|
|
S. S. Negus, M. B. Gatch, and N. K. Mello Discriminative Stimulus Effects of a Cocaine/Heroin "Speedball" Combination in Rhesus Monkeys J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1123 - 1136. [Abstract] [Full Text]
|
|
|
|
|
|
N. K. Mello and S. S. Negus The Effects of Buprenorphine on Self-administration of Cocaine and Heroin "Speedball" Combinations and Heroin Alone by Rhesus Monkeys J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 444 - 456. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. E. Schlaepfer, E. C. Strain, B. D. Greenberg, K. L. Preston, E. Lancaster, G. E. Bigelow, P. E. Barta, and G. D. Pearlson Site of Opioid Action in the Human Brain: Mu and Kappa Agonists' Subjective and Cerebral Blood Flow Effects Am J Psychiatry, April 1, 1998; 155(4): 470 - 473. [Abstract] [Full Text]
|
|
|
|
|
|
P. M. Kunko, D. French, and S. Izenwasser Alterations in Locomotor Activity during Chronic Cocaine Administration: Effect on Dopamine Receptors and Interaction with Opioids J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 277 - 284. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. K. Staley, R. B. Rothman, K. C. Rice, J. Partilla, and D. C. Mash kappa 2 Opioid Receptors in Limbic Areas of the Human Brain Are Upregulated by Cocaine in Fatal Overdose Victims J. Neurosci., November 1, 1997; 17(21): 8225 - 8233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Kimmel and S. G. Holtzman Mu Opioid Agonists Potentiate Amphetamine- and Cocaine-Induced Rotational Behavior in the Rat J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 734 - 746. [Abstract] [Full Text]
|
|
|
|
|
|
S. S. Negus, N. K. Mello, P. S. Portoghese, and C.-E. Lin Effects of Kappa Opioids on Cocaine Self-Administration by Rhesus Monkeys J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 44 - 55. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
